Conversely, variant CYP19A1/rs4646-carriers, who also carry the variant PPARGC1A Thr612Met allele had a 38 % decreased risk of BC (IRR = 0.62; 95 % CI: 0.36-1.08) (Additional file 8). This evidence concerns the gene PPARGC1A and breast cancer.